APOBEC3 proteins and genomic stability

References

• Hamilton CE, Papavasiliou FN, Rosenberg BR. Diverse functions for DNA and RNA editing in the immune system. RNA Biol 2010; 7:220 - 228; PMID: 20220309; http://dx.doi.org/10.4161/rna.7.2.11344
   PubMed Web of Science ®Google Scholar
• Conticello SG, Langlois MA, Yang Z, Neuberger MS. DNA deamination in immunity: AID in the context of its APOBEC relatives. Adv Immunol 2007; 94:37 - 73; PMID: 17560271; http://dx.doi.org/10.1016/S0065-2776(06)94002-4
   PubMedGoogle Scholar
• Di Noia JM, Neuberger MS. Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem 2007; 76:1 - 22; PMID: 17328676; http://dx.doi.org/10.1146/annurev.biochem.76.061705.090740
   PubMed Web of Science ®Google Scholar
• Stavnezer J, Guikema JE, Schrader CE. Mechanism and regulation of class switch recombination. Annu Rev Immunol 2008; 26:261 - 292; PMID: 18370922; http://dx.doi.org/10.1146/annurev.immunol.26.021607.090248
   PubMed Web of Science ®Google Scholar
• Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 2008; 26:317 - 353; PMID: 18304004; http://dx.doi.org/10.1146/annurev.immunol.26.021607.090350
   PubMed Web of Science ®Google Scholar
• Harris RS, Liddament MT. Retroviral restriction by APOBEC proteins. Nat Rev Immunol 2004; 4:868 - 877; PMID: 15516966; http://dx.doi.org/10.1038/nri1489
   PubMed Web of Science ®Google Scholar
• Holmes RK, Malim MH, Bishop KN. APOBEC-mediated viral restriction: not simply editing?. Trends Biochem Sci 2007; 32:118 - 128; PMID: 17303427; http://dx.doi.org/10.1016/j.tibs.2007.01.004
   PubMed Web of Science ®Google Scholar
• Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, et al. DNA deamination mediates innate immunity to retroviral infection. Cell 2003; 113:803 - 809; PMID: 12809610; http://dx.doi.org/10.1016/S0092-8674(03)00423-9
   PubMed Web of Science ®Google Scholar
• Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003; 424:99 - 103; PMID: 12808466; http://dx.doi.org/10.1038/nature01709
   PubMed Web of Science ®Google Scholar
• Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003; 424:94 - 98; PMID: 12808465; http://dx.doi.org/10.1038/nature01707
   PubMed Web of Science ®Google Scholar
• Lecossier D, Bouchonnet F, Clavel F, Hance AJ. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 2003; 300:1112; PMID: 12750511; http://dx.doi.org/10.1126/science.1083338
   PubMed Web of Science ®Google Scholar
• Suspène R, Guétard D, Henry M, Sommer P, Wain-Hobson S, Vartanian JP. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci USA 2005; 102:8321 - 8326; PMID: 15919829; http://dx.doi.org/10.1073/pnas.0408223102
   PubMed Web of Science ®Google Scholar
• Vartanian JP, Guetard D, Henry M, Wain-Hobson S. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 2008; 320:230 - 233; PMID: 18403710; http://dx.doi.org/10.1126/science.1153201
   PubMed Web of Science ®Google Scholar
• Yang B, Chen K, Zhang C, Huang S, Zhang H. Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA. J Biol Chem 2007; 282:11667 - 11675; PMID: 17272283; http://dx.doi.org/10.1074/jbc.M606864200
   PubMed Web of Science ®Google Scholar
• Kaiser SM, Emerman M. Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G. J Virol 2006; 80:875 - 882; PMID: 16378989; http://dx.doi.org/10.1128/JVI.80.2.875-82.2006
   PubMed Web of Science ®Google Scholar
• Mbisa JL, Barr R, Thomas JA, Vandegraaff N, Dorweiler IJ, Svarovskaia ES, et al. Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J Virol 2007; 81:7099 - 7110; PMID: 17428871; http://dx.doi.org/10.1128/JVI.00272-07
   PubMed Web of Science ®Google Scholar
• Schumacher AJ, Haché G, Macduff DA, Brown WL, Harris RS. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD and human immunodeficiency virus type 1 restriction. J Virol 2008; 82:2652 - 2660; PMID: 18184715; http://dx.doi.org/10.1128/JVI.02391-07
   PubMed Web of Science ®Google Scholar
• Stenglein MD, Burns MB, Li M, Lengyel J, Harris RS. APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol 2010; 17:222 - 229; PMID: 20062055; http://dx.doi.org/10.1038/nsmb.1744
   PubMed Web of Science ®Google Scholar
• Chen H, Lilley CE, Yu Q, Lee DV, Chou J, Narvaiza I, et al. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr Biol 2006; 16:480 - 485; PMID: 16527742; http://dx.doi.org/10.1016/j.cub.2006.01.031
   PubMed Web of Science ®Google Scholar
• Suspène R, Henry M, Guillot S, Wain-Hobson S, Vartanian JP. Recovery of APOBEC3-edited human immunodeficiency virus G→A hypermutants by differential DNA denaturation PCR. J Gen Virol 2005; 86:125 - 129; PMID: 15604439; http://dx.doi.org/10.1099/vir.0.80426-0
   PubMed Web of Science ®Google Scholar
• Rosenberg BR, Papavasiliou FN. Beyond SHM and CSR: AID and related cytidine deaminases in the host response to viral infection. Adv Immunol 2007; 94:215 - 244; PMID: 17560276; http://dx.doi.org/10.1016/S0065-2776(06)94007-3
   PubMedGoogle Scholar
• Petit V, Vartanian JP, Wain-Hobson S. Powerful mutators lurking in the genome. Philos Trans Soc Lond B Biol Sci 2009; 364:705 - 715; PMID: 19042181; http://dx.doi.org/10.1098/rstb.2008.0272
   PubMed Web of Science ®Google Scholar
• Liu M, Schatz DG. Balancing AID and DNA repair during somatic hypermutation. Trends Immunol 2009; 30:173 - 181; PMID: 19303358; http://dx.doi.org/10.1016/j.it.2009.01.007
   PubMed Web of Science ®Google Scholar
• Nagaoka H, Tran TH, Kobayashi M, Aida M, Honjo T. Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity. Int Immunol 2010; 22:227 - 235; PMID: 20207715; http://dx.doi.org/10.1093/intimm/dxq023
   PubMed Web of Science ®Google Scholar
• Liu M, Duke JL, Richter DJ, Vinuesa CG, Goodnow CC, Kleinstein SH, et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008; 451:841 - 845; PMID: 18273020; http://dx.doi.org/10.1038/nature06547
   PubMed Web of Science ®Google Scholar
• Staszewski O, Baker RE, Ucher AJ, Martier R, Stavnezer J, Guikema JE. Activation-induced cytidine deaminase induces reproducible DNA breaks at many non-Ig Loci in activated B cells. Mol Cell 2011; 41:232 - 242; PMID: 21255732; http://dx.doi.org/10.1016/j.molcel.2011.01.007
   PubMed Web of Science ®Google Scholar
• Tsai AG, Lu H, Raghavan SC, Muschen M, Hsieh CL, Lieber MR. Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity. Cell 2008; 135:1130 - 1142; PMID: 19070581; http://dx.doi.org/10.1016/j.cell.2008.10.035
   PubMed Web of Science ®Google Scholar
• Robbiani DF, Bunting S, Feldhahn N, Bothmer A, Camps J, Deroubaix S, et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol Cell 2009; 36:631 - 641; PMID: 19941823; http://dx.doi.org/10.1016/j.molcel.2009.11.007
   PubMed Web of Science ®Google Scholar
• Hasham MG, Donghia NM, Coffey E, Maynard J, Snow KJ, Ames J, et al. Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination. Nat Immunol 2010; 11:820 - 826; PMID: 20657597; http://dx.doi.org/10.1038/ni.1909
   PubMed Web of Science ®Google Scholar
• Wang M, Yang Z, Rada C, Neuberger MS. AID upmutants isolated using a high-throughput screen highlight the immunity/cancer balance limiting DNA deaminase activity. Nat Struct Mol Biol 2009; 16:769 - 776; PMID: 19543289; http://dx.doi.org/10.1038/nsmb.1623
   PubMed Web of Science ®Google Scholar
• Landry S, Narvaiza I, Linfesty DC, Weitzman MD. APOBEC3A can activate the DNA damage response and cause cell cycle arrest. EMBO Rep 2011; 12:444 - 450; PMID: 21460793; http://dx.doi.org/10.1038/embor.2011.46
   PubMed Web of Science ®Google Scholar
• Fernandez-Capetillo O, Celeste A, Nussenzweig A. Focusing on foci: H2AX and the recruitment of DNA-damage response factors. Cell Cycle 2003; 2:426 - 427; PMID: 12963833; http://dx.doi.org/10.4161/cc.2.5.509
   PubMed Web of Science ®Google Scholar
• Bransteitter R, Pham P, Scharff MD, Goodman MF. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc Natl Acad Sci USA 2003; 100:4102 - 4107; PMID: 12651944; http://dx.doi.org/10.1073/pnas.0730835100
   PubMed Web of Science ®Google Scholar
• Suspène R, Sommer P, Henry M, Ferris S, Guetard D, Pochet S, et al. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res 2004; 32:2421 - 2429; PMID: 15121899; http://dx.doi.org/10.1093/nar/gkh554
   PubMed Web of Science ®Google Scholar
• Yu Q, König R, Pillai S, Chiles K, Kearney M, Palmer S, et al. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol 2004; 11:435 - 442
   PubMed Web of Science ®Google Scholar
• Chaudhuri J, Tian M, Khuong C, Chua K, Pinaud E, Alt FW. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 2003; 422:726 - 730; PMID: 12692563; http://dx.doi.org/10.1038/nature01574
   PubMed Web of Science ®Google Scholar
• Ramiro AR, Stavropoulos P, Jankovic M, Nussenzweig MC. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat Immunol 2003; 4:452 - 456; PMID: 12692548; http://dx.doi.org/10.1038/ni920
   PubMed Web of Science ®Google Scholar
• Pham P, Bransteitter R, Petruska J, Goodman MF. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 2003; 424:103 - 107; PMID: 12819663; http://dx.doi.org/10.1038/nature01760
   PubMed Web of Science ®Google Scholar
• Shen HM, Poirier MG, Allen MJ, North J, Lal R, Widom J, et al. The activation-induced cytidine deaminase (AID) efficiently targets DNA in nucleosomes but only during transcription. J Exp Med 2009; 206:1057 - 1071; PMID: 19380635; http://dx.doi.org/10.1084/jem.20082678
   PubMed Web of Science ®Google Scholar
• Khobta A, Epe B. Interactions between DNA damage, repair and transcription. Mutat Res 2011; In press
   PubMed Web of Science ®Google Scholar
• Suspène R, Aynaud MM, Guetard D, Henry M, Eckhoff G, Marchio A, et al. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci USA 2011; 108:4858 - 4863; PMID: 21368204; http://dx.doi.org/10.1073/pnas.1009687108
   PubMed Web of Science ®Google Scholar
• Imai K, Catalan N, Plebani A, Marodi L, Sanal O, Kumaki S, et al. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest 2003; 112:136 - 142; PMID: 12840068
   PubMed Web of Science ®Google Scholar
• Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO, et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999; 274:18470 - 18476; PMID: 10373455; http://dx.doi.org/10.1074/jbc.274.26.18470
   PubMed Web of Science ®Google Scholar
• Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102:553 - 563; PMID: 11007474; http://dx.doi.org/10.1016/S0092-8674(00)00078-7
   PubMed Web of Science ®Google Scholar
• Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000; 102:565 - 575; PMID: 11007475; http://dx.doi.org/10.1016/S0092-8674(00)00079-9
   PubMed Web of Science ®Google Scholar
• Delker RK, Fugmann SD, Papavasiliou FN. A coming-of-age story: activation-induced cytidine deaminase turns 10. Nat Immunol 2009; 10:1147 - 1153; PMID: 19841648; http://dx.doi.org/10.1038/ni.1799
   PubMed Web of Science ®Google Scholar
• Crouch EE, Li Z, Takizawa M, Fichtner-Feigl S, Gourzi P, Montano C, et al. Regulation of AID expression in the immune response. J Exp Med 2007; 204:1145 - 1156; PMID: 17452520; http://dx.doi.org/10.1084/jem.20061952
   PubMed Web of Science ®Google Scholar
• Dorsett Y, McBride KM, Jankovic M, Gazumyan A, Thai TH, Robbiani DF, et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008; 28:630 - 638; PMID: 18455451; http://dx.doi.org/10.1016/j.immuni.2008.04.002
   PubMed Web of Science ®Google Scholar
• Patenaude AM, Orthwein A, Hu Y, Campo VA, Kavli B, Buschiazzo A, et al. Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat Struct Mol Biol 2009; 16:517 - 527; PMID: 19412186; http://dx.doi.org/10.1038/nsmb.1598
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Kitaura Y, Gu H, Dalla-Favera R. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc Natl Acad Sci USA 2006; 103:395 - 400; PMID: 16387847; http://dx.doi.org/10.1073/pnas.0509969103
   PubMed Web of Science ®Google Scholar
• Basu U, Franklin A, Alt FW. Post-translational regulation of activation-induced cytidine deaminase. Philos Trans R Soc Lond B Biol Sci 2009; 364:667 - 673; PMID: 19010772; http://dx.doi.org/10.1098/rstb.2008.0194
   PubMed Web of Science ®Google Scholar
• Aoufouchi S, Faili A, Zober C, D'Orlando O, Weller S, Weill JC, et al. Proteasomal degradation restricts the nuclear lifespan of AID. J Exp Med 2008; 205:1357 - 1368; PMID: 18474627; http://dx.doi.org/10.1084/jem.20070950
   PubMed Web of Science ®Google Scholar
• Xu Z, Fulop Z, Wu G, Pone EJ, Zhang J, Mai T, et al. 14-3-3 adaptor proteins recruit AID to 5′-AGCT-3′-rich switch regions for class switch recombination. Nat Struct Mol Biol 2010; 17:1124 - 1135; PMID: 20729863; http://dx.doi.org/10.1038/nsmb.1884
   PubMed Web of Science ®Google Scholar
• Orthwein A, Patenaude AM, Affar el B, Lamarre A, Young JC, Di Noia JM. Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90. J Exp Med 2010; 207:2751 - 2765; PMID: 21041454; http://dx.doi.org/10.1084/jem.20101321
   PubMed Web of Science ®Google Scholar
• Storck S, Aoufouchi S, Weill JC, Reynaud CA. AID and partners: for better and (not) for worse. Curr Opin Immunol 2011; 23:337 - 344; PMID: 21439803; http://dx.doi.org/10.1016/j.coi.2011.02.002
   PubMed Web of Science ®Google Scholar
• Okazaki IM, Kotani A, Honjo T. Role of AID in tumorigenesis. Adv Immunol 2007; 94:245 - 273; PMID: 17560277; http://dx.doi.org/10.1016/S0065-2776(06)94008-5
   PubMedGoogle Scholar
• Marusawa H, Takai A, Chiba T. Role of activation-induced cytidine deaminase in inflammation-associated cancer development. Adv Immunol 2011; 111:109 - 141; PMID: 21970953; http://dx.doi.org/10.1016/B978-0-12-385991-4.00003-9
   PubMed Web of Science ®Google Scholar
• Peng G, Lei KJ, Jin W, Greenwell-Wild T, Wahl SM. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J Exp Med 2006; 203:41 - 46; PMID: 16418394; http://dx.doi.org/10.1084/jem.20051512
   PubMed Web of Science ®Google Scholar
• Bonvin M, Achermann F, Greeve I, Stroka D, Keogh A, Inderbitzin D, et al. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 2006; 43:1364 - 1374; PMID: 16729314; http://dx.doi.org/10.1002/hep.21187
   PubMed Web of Science ®Google Scholar
• Stopak KS, Chiu YL, Kropp J, Grant RM, Greene WC. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages and dendritic cells. J Biol Chem 2007; 282:3539 - 3546; PMID: 17110377; http://dx.doi.org/10.1074/jbc.M610138200
   PubMed Web of Science ®Google Scholar
• Koning FA, Newman EN, Kim EY, Kunstman KJ, Wolinsky SM, Malim MH. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol 2009; 83:9474 - 9485; PMID: 19587057; http://dx.doi.org/10.1128/JVI.01089-09
   PubMed Web of Science ®Google Scholar
• Pauklin S, Sernandez IV, Bachmann G, Ramiro AR, Petersen-Mahrt SK. Estrogen directly activates AID transcription and function. J Exp Med 2009; 206:99 - 111; PMID: 19139166; http://dx.doi.org/10.1084/jem.20080521
   PubMed Web of Science ®Google Scholar
• Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res 2010; 38:4274 - 4284; PMID: 20308164; http://dx.doi.org/10.1093/nar/gkq174
   PubMed Web of Science ®Google Scholar
• Rose KM, Marin M, Kozak SL, Kabat D. Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus. J Biol Chem 2004; 279:41744 - 41749; PMID: 15297452; http://dx.doi.org/10.1074/jbc.M406760200
   PubMed Web of Science ®Google Scholar
• Sarkis PT, Ying S, Xu R, Yu XF. STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha. J Immunol 2006; 177:4530 - 4540; PMID: 16982890
   PubMed Web of Science ®Google Scholar
• Muckenfuss H, Kaiser JK, Krebil E, Battenberg M, Schwer C, Cichutek K, et al. Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene. Nucleic Acids Res 2007; 35:3784 - 3796; PMID: 17517765; http://dx.doi.org/10.1093/nar/gkm340
   PubMed Web of Science ®Google Scholar
• Farrow MA, Kim EY, Wolinsky SM, Sheehy AM. NFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3G. J Biol Chem 2011; 286:2567 - 2577; PMID: 21078663; http://dx.doi.org/10.1074/jbc.M110.154377
   PubMed Web of Science ®Google Scholar
• Gallois-Montbrun S, Kramer B, Swanson CM, Byers H, Lynham S, Ward M, et al. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol 2007; 81:2165 - 2178; PMID: 17166910; http://dx.doi.org/10.1128/JVI.02287-06
   PubMed Web of Science ®Google Scholar
• Huang J, Liang Z, Yang B, Tian H, Ma J, Zhang H. Derepression of MicroRNA-mediated Protein Translation Inhibition by Apolipoprotein B mRNA-editing Enzyme Catalytic Polypeptide-like 3G (APOBEC3G) and Its Family Members. J Biol Chem 2007; 282:33632 - 33640; PMID: 17848567; http://dx.doi.org/10.1074/jbc.M705116200
   PubMed Web of Science ®Google Scholar
• Huthoff H, Autore F, Gallois-Montbrun S, Fraternali F, Malim MH. RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog 2009; 5:1000330; PMID: 19266078; http://dx.doi.org/10.1371/journal.ppat.1000330
   PubMed Web of Science ®Google Scholar
• Iwatani Y, Takeuchi H, Strebel K, Levin JG. Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect. J Virol 2006; 80:5992 - 6002; PMID: 16731938; http://dx.doi.org/10.1128/JVI.02680-05
   PubMed Web of Science ®Google Scholar
• Kozak SL, Marin M, Rose KM, Bystrom C, Kabat D. The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J Biol Chem 2006; 281:29105 - 29119; PMID: 16887808; http://dx.doi.org/10.1074/jbc.M601901200
   PubMed Web of Science ®Google Scholar
• Kreisberg JF, Yonemoto W, Greene WC. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J Exp Med 2006; 203:865 - 870; PMID: 16606671; http://dx.doi.org/10.1084/jem.20051856
   PubMed Web of Science ®Google Scholar
• Shirakawa K, Takaori-Kondo A, Yokoyama M, Izumi T, Matsui M, Io K, et al. Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. Nat Struct Mol Biol 2008; 15:1184 - 1191
   PubMed Web of Science ®Google Scholar
• Stenglein MD, Matsuo H, Harris RS. Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization. J Virol 2008; 82:9591 - 9599; PMID: 18667511; http://dx.doi.org/10.1128/JVI.02471-07
   PubMed Web of Science ®Google Scholar
• Chiu YL, Witkowska HE, Hall SC, Santiago M, Soros VB, Esnault C, et al. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc Natl Acad Sci USA 2006; 103:15588 - 15593; PMID: 17030807; http://dx.doi.org/10.1073/pnas.0604524103
   PubMed Web of Science ®Google Scholar
• Bennett RP, Presnyak V, Wedekind JE, Smith HC. Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding. J Biol Chem 2008; 283:7320 - 7327; PMID: 18165230; http://dx.doi.org/10.1074/jbc.M708567200
   PubMed Web of Science ®Google Scholar
• McDougall WM, Smith HC. Direct evidence that RNA inhibits APOBEC3G ssDNA cytidine deaminase activity. Biochem Biophys Res Commun 2011; 412:612 - 617; PMID: 21856286; http://dx.doi.org/10.1016/j.bbrc.2011.08.009
   PubMed Web of Science ®Google Scholar
• Thielen BK, Klein KC, Walker LW, Rieck M, Buckner JH, Tomblingson GW, et al. T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity. PLoS Pathog 2007; 3:1320 - 1334; PMID: 17892323; http://dx.doi.org/10.1371/journal.ppat.0030135
   PubMed Web of Science ®Google Scholar
• Wichroski MJ, Robb GB, Rana TM. Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies. PLoS Pathog 2006; 2:41; PMID: 16699599; http://dx.doi.org/10.1371/journal.ppat.0020041
   PubMed Web of Science ®Google Scholar
• Bogerd HP, Wiegand HL, Hulme AE, Garcia-Perez JL, O'Shea KS, Moran JV, et al. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci USA 2006; 103:8780 - 8785; PMID: 16728505; http://dx.doi.org/10.1073/pnas.0603313103
   PubMed Web of Science ®Google Scholar
• Niewiadomska AM, Tian C, Tan L, Wang T, Sarkis PTN, Yu XF. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association. J Virol 2007; 81:9577 - 9583; PMID: 17582006; http://dx.doi.org/10.1128/JVI.02800-06
   PubMed Web of Science ®Google Scholar
• Mehta A, Kinter MT, Sherman NE, Driscoll DM. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol Cell Biol 2000; 20:1846 - 1854; PMID: 10669759; http://dx.doi.org/10.1128/MCB.20.5.1846-54.2000
   PubMed Web of Science ®Google Scholar
• Lellek H, Kirsten R, Diehl I, Apostel F, Buck F, Greeve J. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J Biol Chem 2000; 275:19848 - 19856; PMID: 10781591; http://dx.doi.org/10.1074/jbc.M001786200
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang X, Tian C, Wang T, Sarkis PTN, Fang Y, et al. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression. Cell Microbiol 2008; 10:112 - 121; PMID: 17672864
   PubMed Web of Science ®Google Scholar
• Smith HC, Bennett RP, Kizilyer A, McDougall WM, Prohaska KM. Functions and regulation of the APOBEC family of proteins. Semin Cell Dev Biol 2011; In press
   PubMed Web of Science ®Google Scholar
• Narvaiza I, Linfesty DC, Greener BN, Hakata Y, Pintel DJ, Logue E, et al. Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase. PLoS Pathog 2009; 5:1000439; PMID: 19461882; http://dx.doi.org/10.1371/journal.ppat.1000439
   PubMed Web of Science ®Google Scholar
• Thielen BK, McNevin JP, McElrath MJ, Hunt BVS, Klein KC, Lingappa JR. Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms. J Biol Chem 2010; 285:27753 - 27766; PMID: 20615867; http://dx.doi.org/10.1074/jbc.M110.102822
   PubMed Web of Science ®Google Scholar
• Bulliard Y, Narvaiza I, Bertero A, Peddi S, Rohrig UF, Ortiz M, et al. Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities. J Virol 2011; 85:1765 - 1776; PMID: 21123384; http://dx.doi.org/10.1128/JVI.01651-10
   PubMed Web of Science ®Google Scholar
• Sweasy JB, Lang T, DiMaio D. Is base excision repair a tumor suppressor mechanism?. Cell Cycle 2006; 5:250 - 259; PMID: 16418580; http://dx.doi.org/10.4161/cc.5.3.2414
   PubMed Web of Science ®Google Scholar
• Berger G, Durand S, Fargier G, Nguyen XN, Cordeil S, Bouaziz S, et al. APOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells. PLoS Pathog 2011; 7:1002221; PMID: 21966267; http://dx.doi.org/10.1371/journal.ppat.1002221
   PubMed Web of Science ®Google Scholar
• Sawyer SL, Emerman M, Malik HS. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol 2004; 2:275; PMID: 15269786; http://dx.doi.org/10.1371/journal.pbio.0020275
   PubMed Web of Science ®Google Scholar
• Kidd JM, Newman TL, Tuzun E, Kaul R, Eichler EE. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet 2007; 3:63; PMID: 17447845; http://dx.doi.org/10.1371/journal.pgen.0030063
   PubMed Web of Science ®Google Scholar
• OhAinle M, Kerns JA, Li MM, Malik HS, Emerman M. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 2008; 4:249 - 259; PMID: 18779051; http://dx.doi.org/10.1016/j.chom.2008.07.005
   PubMed Web of Science ®Google Scholar
• Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005; 436:1186 - 1190; PMID: 15995699; http://dx.doi.org/10.1038/nature03884
   PubMed Web of Science ®Google Scholar
• Gasser S, Raulet DH. The DNA damage response arouses the immune system. Cancer Res 2006; 66:3959 - 3962; PMID: 16618710; http://dx.doi.org/10.1158/0008-5472.CAN-05-4603
   PubMed Web of Science ®Google Scholar
• Gourzi P, Leonova T, Papavasiliou FN. A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity 2006; 24:779 - 786; PMID: 16782033; http://dx.doi.org/10.1016/j.immuni.2006.03.021
   PubMed Web of Science ®Google Scholar
• Norman JM, Mashiba M, McNamara LA, Onafuwa-Nuga A, Chiari-Fort E, Shen W, et al. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat Immunol 2011; 12:975 - 983; PMID: 21874023; http://dx.doi.org/10.1038/ni.2087
   PubMed Web of Science ®Google Scholar
• Zaheen A, Boulianne B, Parsa JY, Ramachandran S, Gommerman JL, Martin A. AID constrains germinal center size by rendering B cells susceptible to apoptosis. Blood 2009; 114:547 - 554; PMID: 19478044; http://dx.doi.org/10.1182/blood-2009-03-211763
   PubMed Web of Science ®Google Scholar
• Barré B, Coqueret O, Perkins ND. Regulation of activity and function of the p52 NFkappaB subunit following DNA damage. Cell Cycle 2010; 9:4795 - 4804; PMID: 21131783; http://dx.doi.org/10.4161/cc.9.24.14245
   PubMed Web of Science ®Google Scholar
• Xu R, Zhang X, Zhang W, Fang Y, Zheng S, Yu XF. Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma. Hepatology 2007; 46:1810 - 1820; PMID: 17847074; http://dx.doi.org/10.1002/hep.21893
   PubMed Web of Science ®Google Scholar
• Komatsu A, Nagasaki K, Fujimori M, Amano J, Miki Y. Identification of novel deletion polymorphisms in breast cancer. Int J Oncol 2008; 33:261 - 270
   PubMed Web of Science ®Google Scholar
• Ding Q, Chang CJ, Xie X, Xia W, Yang JY, Wang SC, et al. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J Clin Invest 2011; 121:4526 - 4536
   PubMed Web of Science ®Google Scholar
• Fritz EL, Papavasiliou FN. Cytidine deaminases: AIDing DNA demethylation?. Genes Dev 2010; 24:2107 - 2114
   PubMed Web of Science ®Google Scholar
• Guo JU, Su Y, Zhong C, Ming GL, Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011; 145:423 - 434; PMID: 21496894; http://dx.doi.org/10.1016/j.cell.2011.03.022
   PubMed Web of Science ®Google Scholar